Elevance Health: EVP & CFO Mark Kaye sold 4,161 shares

What happened Mark Kaye, EVP & CFO, had 4,161 shares withheld/disposed at $386.43 per share on Oct 2, 2026 for $1,607,935 to pay tax liability. The filing also shows an award/acquisition of 2,627 shares at $0 on Oct 2, 2026 representing performance-based restricted share units whose restrictions lapsed on Oct 2, 2026.

Key details

• Transaction dates and prices: Oct 2, 2026 — 4,161 shares withheld/disposed at $386.43 for $1,607,935; Oct 2, 2026 — 2,627 shares awarded at $0 (acquired).
• Shares owned after the transaction: as reported on the Form 4 (not provided in this summary).
• Footnotes: F1 — payment of tax liability by withholding stock incident to the vesting of previously granted restricted stock; F2 — represents performance-based restricted share units; restrictions lapsed on Oct 2, 2026.
• Form filed: Oct 6, 2026.

Why it may matter The filing shows shares were withheld to satisfy tax withholding on vested performance-based restricted share units rather than a separate open-market sale; 2,627 performance-based shares vested and 4,161 shares were withheld/disposed to cover taxes. A filing does not show why the insider traded or why the company acted.